SEC Form 4 · accession 0001209191-18-021671
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Boyd
Officer — President and CFO
Period of report
Mar 25, 2018
Accepted (ET)
Mar 26, 2018 · 7:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 25, 2018 | A | 34,373 | A | — | — | Common Stock | 34,373 | 34,373 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock.
- F2The restricted stock units vest with respect to 100% of the total shares subject to the grant on March 25, 2018. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.